Enzyme flexibility, solvent and 'weak' interactions characterize thrombin-ligand interactions: implications for drug design.
Engh, R.A., Brandstetter, H., Sucher, G., Eichinger, A., Baumann, U., Bode, W., Huber, R., Poll, T., Rudolph, R., von der Saal, W.(1996) Structure 4: 1353-1362
- PubMed: 8939759 
- DOI: https://doi.org/10.1016/s0969-2126(96)00142-6
- Primary Citation of Related Structures:  
1UVS, 1UVT, 1UVU - PubMed Abstract: 
The explosive growth in the rate of X-ray determination of protein structures is fuelled largely by the expectation that structural information will be useful for pharmacological and biotechnological applications. For example, there have been intensive efforts to develop orally administrable antithrombotic drugs using information about the crystal structures of blood coagulation factors, including thrombin ...